A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium

NCT00949975 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

838

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: AZD9668
DRUG: AZD9668
DRUG: AZD9668
DRUG: AZD9668 Placebo

Sponsor

AstraZeneca